Opens in a new tab or window SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body ...

Mounjaro and Zepbound. The medical news website Medscape first reported the warning label update on Wednesday. GLP-1s — which ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk's weight-loss and diabetes drugs but cannot ...

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster ...

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed a "shocking first miss" during its most recent ...

But after gaining more than 20 pounds during undergraduate and graduate school and feeling unhappy with her weight, the ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...